Hôpital Henri-Mondor AP-HP

77 currently recruiting clinical trials
Create patient profile for matching
Phase 2 Lymphoma #NCT06482684 #2022-502405-15-01
B cell lymphoma Mantel cell lymphoma Early (stage I and II) Disseminated (stage III and IV) None > 60 ml/min None Systemic Treatment-Naive
Hôpital Henri-Mondor AP-HP (Créteil)
Ludwig-Maximilians - Université de Munich
Phase 2 Stomach and esophageal cancer #NCT06253611 #2023-506753-38-00
Stomach Oesogastric junction Esophagus Adenocarcinoma Locally Advanced Metastatic None Systemic Treatment-Naive
HER2 Immunotherapy
Hôpital Henri-Mondor AP-HP (Créteil)
GERCOR - Groupe Coopératif Multidisciplinaire d'Oncologie
Phase 2 Liver and bile duct cancer #NCT05528952
Hepatocellular carcinoma Locally Advanced Metastatic Unhealthy A None Systemic Treatment-Naive
Immunotherapy
Hôpital Henri-Mondor AP-HP (Créteil)
CHU de Besançon
Phase 2 Colon cancer Rectal cancer Anal cancer Pancreas cancer Liver and bile duct cancer Stomach and esophageal cancer #NCT06475352
Locally Advanced Metastatic None Systemic Treatment-Naive
Hôpital Henri-Mondor AP-HP (Créteil)
UNICANCER
Phase 1 / Phase 2 Lymphoma CLL & Richter's syndrome #NCT05006716
B cell lymphoma CLL (Chronic Lymphocytic Leukemia) Richter's syndrome Large B cell lymphoma Mantel cell lymphoma Follicular lymphoma Marginal zone lymphoma Waldenström lymphoma Lymphocytic lymphoma None 1 2 3 or more
Systemic Treatment-Naive
Hôpital Henri-Mondor AP-HP (Créteil)
BeOne Medecines
Phase 1 / Phase 2 Prostate cancer #NCT07190300 #2025-521873-15-00
Adenocarcinoma Metastatic Hormone-sensitive None Hormone therapy Hormone therapy
Internal Vectorised Radiotherapy (IVR)
Hôpital Henri-Mondor AP-HP (Créteil)
Novartis
Phase 1 / Phase 2 Acute leukemia #NCT05580861 #2024-513084-38-00
Acute myeloid leukemia (AML) None > 60 ml/min 50-60 ml/min None Systemic Treatment-Naive
FLT3-ITD
Hôpital Henri-Mondor AP-HP (Créteil)
Assistance Publique - Hôpitaux de Paris
Phase 1 / Phase 2 Lymphoma #NCT06090539
B cell lymphoma Large B cell lymphoma Follicular lymphoma Indolent transformed lymphoma None 2 3 or more
Systemic Treatment-Naive Car-T
Hôpital Henri-Mondor AP-HP (Créteil)
Bristol-Myers Squibb
Phase 1 / Phase 2 Lymphoma #NCT06495723 #2023-509648-88-00
Escalade et extension de dose
T cell lymphoma Peripheral T cell lymphoma None 1 2 3 or more Chemotherapy
Systemic Treatment-Naive
Hôpital Henri-Mondor AP-HP (Créteil)
Xenothera SAS
Phase 1 / Phase 2 Bladder / Urinary Tract / Urethral cancer #NCT06637423
Non-invasive bladder cancer Urothelial carcinoma Localized 1 2 3 or more
Systemic Treatment-Naive
Hôpital Henri-Mondor AP-HP (Créteil)
Merck Sharp & Dohme LLC